IPCALAB logo

IPCA Laboratories LTD

IPCALAB·NSE·
1,986.50 +11.60 (+0.59%)
Market Cap50446.93 Cr
PE Ratio44.16
Volume2,11,028
Day High - Low1994.20 - 1949.30
52W High-Low1994.20 - 1251.60
DocStoX Score
5.3/10
Weak
Fair Value
Sign in to see
ROE
16.00%
Strong
P/E
44.16x
Expensive
Debt / Equity
0.04
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 500NIFTY MIDCAP 150NIFTY PHARMA
Day1949
1994
52W1252
1994
DocStoX take

Supported by risk (9.5) and momentum (7.5), but held back by valuation (0.1). Risk looks strong at 9.5, but that is offset by valuation at 0.1 and growth at 2.6. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.3
/10
Weak
Quality
Solid
ROE 16.0%
Valuation
Expensive
P/E 44.2×
Growth
Flat
Revenue +12.3% 5Y CAGR
Risk
Low risk
D/E 0.04
Momentum
Strong
99% of 52-week range

At a glance

Market Cap
₹50,447 Cr
52W High / Low
₹1994 / ₹1252
Dividend Yield
0.31%
Promoter Holding
44.72%
EPS (TTM)
₹44.98
Book Value
₹318.00

Key highlights

  • Low leverage — D/E 0.04
  • Profitable in all of the last 5 years
  • Valuation is weak (0.1/10)
2 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

IPCA LABORATORIES LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.